Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like Why You Want to Keep This Small $2 Biotech Stock On Your Radar August 1, 2017 Loxo Oncology Announces The Closing Of Its Follow-On Offering Of Common Stock And Full Exercise Of The Underwriters??? Option To Purchase Additional Shares June 20, 2017 Arcturus Rockets on New Hep B RNA Deal With Johnson & Johnson October 18, 2017
Loxo Oncology Announces The Closing Of Its Follow-On Offering Of Common Stock And Full Exercise Of The Underwriters??? Option To Purchase Additional Shares June 20, 2017
